Next Generation Sequencing: RNA-Seq
About This Webcast
Next Generation - RNA sequencing (RNA-seq) has become an indispensable tool for transcriptome-wide analysis of differential gene expression and differential splicing of mRNAs. Several different RNA-seq methods are available for studying different aspects of RNA biology, including single-cell gene expression, translation (the translatome) and RNA structure (the structurome). Together with new long-read and direct RNA-seq technologies and better computational tools for data analysis, innovations in RNA-seq are contributing to a fuller understanding of RNA biology, from when and where transcription occurs to the folding and intermolecular interactions that govern RNA function. Library preparation is a critical part of the NGS workflow; successful sequencing requires the generation of high-quality libraries of sufficient yield. High performance is required from ever-decreasing input quantities and from samples of lower quality. At the same time, the need is increasing for faster, automatable protocols that perform reliably and do not compromise the quality of the libraries produced. Improvements across the entire NGS workflow has allowed RNA-Seq to evolve into a versatile, affordable, and streamlined tool for studying various sample types in evermore challenging applications. In this webinar, Dr Selva Ramasubramanian will provide an overview of RNA-Seq. The topics covered will include: Technological Evolution of RNA Sequencing Designing an RNA Sequencing Run Ribosomal RNA depletion and RNA Library Preparation RNA Sequencing Methods Current Challenges in RNA Sequencing Library Preparation NEB Tools and Resources
Speakers
Selva Ramasubramanian, PhD
Field Application Scientist , New England Biolabs
Selva Ramasubramanian, PhD,is a Field Application Scientist at New England Biolabs, ANZ. She joined the team in July 2019 as part of the new NEB Australia subsidiary and provides local support to our customers in Australia and New Zealand. Selva has acquired knowledge and skills in a broad range of Cellular and Molecular biology techniques throughout her career which has included a PhD at the Max Planck Institute in Germany, Biopharmaceutical experience in Monoclonal Antibody Characterization, and Management of the Single Cell Genomics Core Facility at Monash Health. In her role at NEB, Selva specialises in RNA biology, CRISPR/Genome editing, and Next Generation Sequencing.